Hematología y Hemoterapia

Resultados: 405
Tipo Título / Nombre Autor(es) Año
Lenalidomide plus R-GDP (R2-GDP) in relapsed/refractory diffuse large b cell lymphoma. Preliminary results of the R2-GDP-GOTEL trial Cruz Merino L de la, Martín García Sancho A, Nogales Fernández E, Carnicero González F, Ríos Herranz E, Cruz Vicente F de la, et al 2019
Mastocitosis Cáceres Hernández S 2019
Mutational Profiling Predicts Clinical Outcomes to Azacytidine and Low Dose Cytarabine Plus Fludarabine (FLUGA) in Elderly Acute Myeloid Leukemia Patients Enrolled in the Pethema Phase III Flugaza Trial Ayal RM, Rapado I, Martínez-Cuadron D, Onecha E, Rufian L, Juarez A, et al 2019
Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies Bogliolo M, Pujol R, Aza-Carmona M, Muñoz-Subirana N, Rodríguez-Santiago B, Casado JA, et al 2019
Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R2-CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previously Untreated Activated B-Cell (ABC)-Type Diffuse Large B-Cell Lymphoma (DLBCL): Health-Related Quality of Life (HRQoL) Analysis of the International Robust Study Chiappella A, Witzig E, Cocks K, Greenwood M, Williams A, Scott DW, et al 2019
Outcomes after Plerixafor Plus FLAG-IDA (PLERIFLAG) Versus FLAG-IDA +/- Gentuzumab for Adult Patients with First Relapsed/Refractory AML: A Propensity Score Analysis from the Pethema Registry Bergua Burgues JM, Cano-Ferri I, Martínez Cuadron D, Boluda B, Martínez Sánchez P, Rodríguez Veiga R, et al 2019
Influence of Age on Treatment with Thrombopoietin Receptor Agonists in Patients with Immune Thrombocytopenia; A Retrospective Multicenter Study Lozano ML, Mingot-Castellano ME, Perera M, Jarque I, Campos RM, González-López TJ, et al 2019
Do Guidelines Influence Diagnostic and Therapeutic Practice in Immune Thrombocytopenia? Results of a Multicenter Retrospective Study Lozano ML, Mingot-Castellano ME, Perera M, Jarque I, Campos RM, González-López TJ, et al 2019
Predictive Factors for Thrombopoietin Receptor Agonist Free Responses in Chronic ITP Patients: A Multicenter Retrospective Study with Long-Term Follow-up Lozano ML, Mingot-Castellano ME, Perera M, Jarque I, Campos RM, González-López TJ, et al 2019
A New Molecular Variant in the PTGS1 Gene That Abrogates Generation of Thromboxane A2 Synthesis and Associates with Platelet Dysfunction and Bleeding Palma Barqueros V, Chan M, Crescente M, Bastida JM, Almarza E, Suarez Varela S, et al 2019